Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 6, 2011, Pages 553-559

  Barot, Megha ^a   Gokulgandhi, Mitan R ^a   Haghnegahdar, Megan ^b   Dalvi, Pranjali ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Shawnee Mission West High School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; GATIFLOXACIN; GLYCOPROTEIN P; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CORNEA EPITHELIUM; DRUG EFFECT; DRUG EXPOSURE; EPITHELIUM CELL; FLOW CYTOMETRY; MICROORGANISM; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPITHELIAL CELLS; FLOW CYTOMETRY; FLUOROQUINOLONES; GENE EXPRESSION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; RABBITS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 81255198800     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0076     Document Type: Article

References (29)

1. Bertino, J.S. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin. Ophthalmol. 3:507-521, 2009.
2. Snyder, R., and Glasser, D. Antibiotic therapy for ocular infection. West J. Med. 161:579-584, 1994.
3. Hughes, L., and Maurice, D. A fresh look at iontophoresis. Arch. Ophthalmol. 102:1825-1829, 1984. (Pubitemid 15184178)
4. Hovding, G. Acute bacterial conjunctivitis. Acta Ophthalmol. 86:5-17, 2008. (Pubitemid 351512464)
5. Bourcier, T., Thomas, F., Borderie, V., Chaumeil, C., and Laroche, L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br. J. Ophthalmol. 87:834-838, 2003. (Pubitemid 36765243)
6. Callegan, M.C., Gilmore, M.S., Gregory, M., et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog. Retin. Eye Res. 26:189-203, 2007. (Pubitemid 46217162)
7. Kowalski, R.P., and Dhaliwal, D.K. Ocular bacterial infections: current and future treatment options. Expert Rev. Anti. Infect. Ther. 3:131-139, 2005. (Pubitemid 40277844)
8. Tovilla-Canales, J.L., Nava, A., Tovilla, Y., and Pomar, J.L. Orbital and periorbital infections. Curr. Opin. Ophthalmol. 12:335-341, 2001. (Pubitemid 32958541)
9. Stratton, C.W. Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg. Infect. Dis. 9:10-16, 2003. (Pubitemid 36110196)
10. Asbell, P.A., Colby, K.A., Deng, S., et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am. J. Ophthalmol. 145:951-958, 2008.
11. Asbell, P.A., Sahm, D.F., Shaw, M., Draghi, D.C., and Brown, N.P. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J. Cataract Refract. Surg. 34:814-818, 2008. (Pubitemid 351615511)
12. Shen, L.L., Mitscher, L.A., Sharma, P.N., O'Donne, T.J., Chu, C.S., Rosen, A.G., and Pernet, A.C. Mechanism of inhibition of DNA gyrase by quinolone antibacterials. A cooperative drugDNA- binding model. Biochemistry 28:2886-2894, 1989.
13. Kwatra, D., Vadlapatla, R.K., Vadlapudi, A.D., Pal, D., and Mitra, A.K. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance. Int. J. Pharm. 395:114-121, 2010.
14. Hooper, D.C. Mode of action of fluoroquinolones. Drugs 58(Suppl 2):6-10, 1999. (Pubitemid 29500078)
15. Hooper, D.C. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. Suppl 2:S24-S28, 2000. (Pubitemid 32269605)
16. Baker, R.S., Flowers, C.W., Jr., Casey, R., Fong, D.S., and Wilson, M.R. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch. Ophthalmol. 114:632-633, 1996. (Pubitemid 26136364)
17. Marchal, S., Merlin, J.L., Colosetti, P., and Finance, C. Influence of the fluoroquinolone ofloxacin on the intrinsic expression of multidrug resistance phenotype in HCT-8 human colon carcinoma cells. Oncol. Res. 11:375-381, 1999.
18. Gottesman, M.M., Fojo, T., and Bates, S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2:48-58, 2002. (Pubitemid 37328807)
19. Dey, S., Patel, J., Anand, B.S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., and Mitra, A.K. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest. Ophthalmol. Vis. Sci. 44:2909-2918, 2003. (Pubitemid 36759752)
20. Karla, P.K., Earla, R., Boddu, S.H., Johnston, T.P., Pal, D., and Mitra, A. Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells. Curr. Eye Res. 34:1-9, 2009.
21. Karla, P.K., Pal, D., Quinn, T., and Mitra, A.K. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. Int. J. Pharm. 336:12-21, 2007. (Pubitemid 46551552)
22. Van Bambeke, F., Michot, J.M., and Tulkens, P.M. Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. J. Antimicrob. Chemother. 51:1067-1077, 2003. (Pubitemid 36622060)
23. Dey, S., Gunda, S., and Mitra, A.K. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J. Pharmacol. Exp. Ther. 311:246-255, 2004. (Pubitemid 39287804)
24. Robey, R.W., To, K.K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., and Bates, S.E. ABCG2: a perspective. Adv. Drug Deliv. Rev. 61:3-13, 2009.
25. Zhang, L., Zhang, Y.D., Strong, J.M., Reynolds, K.S., and Huang, S.M. A regulatory viewpoint on transporter-based drug interactions. Xenobiotica 38:709-724, 2008.
26. Wittwer, C.T., Herrmann, M.G., Gundry, C.N., and Elenitoba-Johnson, K.S. Real-time multiplex PCR assays. Methods 25:430-442, 2001. (Pubitemid 34164015)
27. Lage, J.M., Leamon, J.H., Pejovic, T., Hamann, S., Lacey, M., Dillon, D., Segraves, R., Vossbrinck, B., Gonzalez, A., Pinkel, D., Albertson, D.G., Costa, J., and Lizardi, P.M. Whole genome analysis of genetic alterations in small DNA sampls using hyperbranched strand displacement amplification and array-CGH. Genome Res. 13:294-307, 2003. (Pubitemid 36581838)
28. Lehnert, M. Chemotherapy resistance in breast cancer. Anticancer Res. 18:2225-2226, 1998. (Pubitemid 28386494)
29. Gottesman, M.M., Pastan, I., and Ambudkar, S.V. Pglycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6:610-617, 1996.